Terms: = Colorectal cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
23 results:
1. Shen-Qi-Ling-Bi Decoction Inhibits colorectal cancer Cell Growth by Inducing Ferroptosis Through Inactivation of PI3K/AKT Signaling Pathway.
Liu L; Ye G; Huang W; He Y; Xie D
DNA Cell Biol; 2024 Jul; 43(7):315-324. PubMed ID: 38884168
[TBL] [Abstract] [Full Text] [Related]
2. Identification of ROS and KEAP1-related genes and verified targets of α-hederin induce cell death for CRC.
Wang G; Zhu ZM; Wang K
Drug Dev Res; 2024 May; 85(3):e22200. PubMed ID: 38747107
[TBL] [Abstract] [Full Text] [Related]
3. nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal cancer: A Prospective Analysis.
Park JM; Kim S; Bae SU; Byun SJ; Seo I; Lee HW
J Korean Med Sci; 2023 Jul; 38(26):e200. PubMed ID: 37401495
[TBL] [Abstract] [Full Text] [Related]
5. Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy.
Chen H; Yin L; Yang J; Ren N; Chen J; Lu Q; Huang Y; Feng Y; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Biol Med; 2023 May; 20(4):297-316. PubMed ID: 37144561
[TBL] [Abstract] [Full Text] [Related]
6. Blockage of nrf2 and autophagy by L-selenocystine induces selective death in nrf2-addicted colorectal cancer cells through p62-Keap-1-nrf2 axis.
Hsu WL; Wang CM; Yao CL; Chen SC; Nien CY; Sun YH; Tseng TY; Luo YH
Cell Death Dis; 2022 Dec; 13(12):1060. PubMed ID: 36539411
[TBL] [Abstract] [Full Text] [Related]
7. [Relationship of diffusion kurtosis imaging parameters with the pathologic type and prognosis of rectal tumors].
Li J; Gao XM; Cheng JL
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1208-1213. PubMed ID: 36380670
[No Abstract] [Full Text] [Related]
8. Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize nrf2.
Han Y; Gao X; Wu N; Jin Y; Zhou H; Wang W; Liu H; Chu Y; Cao J; Jiang M; Yang S; Shi Y; Xie X; Chen F; Han Y; Qin W; Xu B; Liang J
Cell Death Dis; 2022 Aug; 13(8):742. PubMed ID: 36038548
[TBL] [Abstract] [Full Text] [Related]
9. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.
Cheng X; Liu Y; Wang J; Chen Y; Robertson AG; Zhang X; Jones SJM; Taubert S
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35368077
[TBL] [Abstract] [Full Text] [Related]
10. Cetuximab promotes RSL3-induced ferroptosis by suppressing the nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
[TBL] [Abstract] [Full Text] [Related]
11. The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markers.
Kabel AM; Ashour AM; Ali DA; Arab HH
Int Immunopharmacol; 2021 Sep; 98():107830. PubMed ID: 34118646
[TBL] [Abstract] [Full Text] [Related]
12. High nrf2 Levels Correlate with Poor prognosis in colorectal cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro.
Torrente L; Maan G; Oumkaltoum Rezig A; Quinn J; Jackson A; Grilli A; Casares L; Zhang Y; Kulesskiy E; Saarela J; Bicciato S; Edwards J; Dinkova-Kostova AT; de la Vega L
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992842
[TBL] [Abstract] [Full Text] [Related]
13. Phytochemical compounds targeting on nrf2 for chemoprevention in colorectal cancer.
Zhu Y; Yang Q; Liu H; Song Z; Chen W
Eur J Pharmacol; 2020 Nov; 887():173588. PubMed ID: 32961170
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 metagene signature is a novel prognostic biomarker in colorectal cancer.
O'Cathail SM; Wu CH; Lewis A; Holmes C; Hawkins MA; Maughan T
Cancer Genet; 2020 Oct; 248-249():1-10. PubMed ID: 32871287
[TBL] [Abstract] [Full Text] [Related]
15. Rosmarinic acid inhibits migration, invasion, and p38/AP-1 signaling via miR-1225-5p in colorectal cancer cells.
Yang K; Shen Z; Zou Y; Gao K
J Recept Signal Transduct Res; 2021 Jun; 41(3):284-293. PubMed ID: 32838607
[TBL] [Abstract] [Full Text] [Related]
16. New addiction to the nrf2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.
Kobayashi A; Waku T
Cancer Sci; 2020 Jan; 111(1):6-14. PubMed ID: 31742837
[TBL] [Abstract] [Full Text] [Related]
17. β-Catenin/TCF4 Complex-Mediated Induction of the
Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
[TBL] [Abstract] [Full Text] [Related]
18. FAM129B, an antioxidative protein, reduces chemosensitivity by competing with nrf2 for Keap1 binding.
Cheng KC; Lin RJ; Cheng JY; Wang SH; Yu JC; Wu JC; Liang YJ; Hsu HM; Yu J; Yu AL
EBioMedicine; 2019 Jul; 45():25-38. PubMed ID: 31262713
[TBL] [Abstract] [Full Text] [Related]
19. p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.
Zhang J; Yang S; Xu B; Wang T; Zheng Y; Liu F; Ren F; Jiang J; Shi H; Zou B; Lu X; Lu S; Dong L
Cell Prolif; 2019 May; 52(3):e12585. PubMed ID: 30793399
[TBL] [Abstract] [Full Text] [Related]
20. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
[Next]
